Maintenance of bronchodilator response for Advair Diskus 250/50 (fluticasone propionate/salmeterol) but not ipratropium/albuterol in patients with COPD

被引：2
|
作者：
Knobil, K [1 ]
Kalberg, C [1 ]
Merchant, K [1 ]
Emmett, A [1 ]
Cicale, M [1 ]
机构：
[1] GlaxoSmithKline, Raleigh, NC USA
来源：
CHEST | 2004年 / 126卷 / 04期
关键词：
D O I：
10.1378/chest.126.4_MeetingAbstracts.807S
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：807S / 807S
页数：1
相关论文
共 50 条
  • [1] Efficacy of Advair Diskus 250/50 (fluticasone propionate/salmeterol) or ipratropium/albuterol in patients with COPD associated with chronic bronchitis and/or emphysema
    Sciurba, FC
    Kalberg, C
    Emmett, A
    Merchant, K
    Brown, C
    Knobil, K
    CHEST, 2004, 126 (04) : 807S - 808S
  • [2] Efficacy of Advair Diskus 250/50 (fluticasone propionate/salmeterol) in patients previously naive to COPD maintenance therapy
    Anzueto, AR
    Sense, W
    Yates, J
    Brown, C
    Knobil, K
    CHEST, 2004, 126 (04) : 808S - 808S
  • [3] A comparison of patient perceived improvement in symptoms after initiating therapy with either Advair Diskus (fluticasone propionate/salmeterol) 250/50 or ipratropium/albuterol
    Knobil, K
    Merchant, K
    Kalberg, C
    Emmett, A
    Cicale, M
    CHEST, 2004, 126 (04) : 806S - 807S
  • [4] Advair diskus 250/50 - Fluticasone 250 pg and salmeterol 50 pg inhalation powder - Glaxosmithkline - Novel therapy for COPD
    不详
    FORMULARY, 2004, 39 (01) : 6 - 7
  • [5] PARTICLE INTERACTIONS OF FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE IN ADVAIR DISKUS®
    Jetzer, Martin
    Morrical, Bradley
    Fergenson, David
    Imanidis, Georgios
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2018, 31 (02) : A24 - A24
  • [6] The efficacy and safety of fluticasone propionate (250 μg)/salmeterol (50 μg) combined in the diskus inhaler for the treatment of COPD
    Hanania, NA
    Darken, P
    Horstman, D
    Reisner, C
    Lee, B
    Davis, S
    Shah, T
    CHEST, 2003, 124 (03) : 834 - 843
  • [7] Effect Of Fluticasone Propionate/Salmeterol (250/50) On Arterial Stiffness In Patients With COPD
    Dransfield, M. T.
    Cockcroft, J.
    Townsend, R.
    Coxson, H. O.
    Sharma, S.
    Rubin, D.
    Emmett, A.
    Cicale, M.
    Crater, G.
    Martinez, F. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [8] Effect of fluticasone propionate/salmeterol (250/50 μg) or salmeterol (50 μg) on COPD exacerbations
    Ferguson, Gary T.
    Anzueto, Antonio
    Fei, Richard
    Emmett, Amanda
    Knobil, Katharine
    Kalberg, Christopher
    RESPIRATORY MEDICINE, 2008, 102 (08) : 1099 - 1108
  • [9] Fluticasone/salmeterol combination (250/50) provides greater improvement in lung function and symptoms than the combination of ipratropium/albuterol in patients with COPD
    Donohue, JF
    Kalberg, C
    Emmett, A
    Merchant, K
    Knobil, K
    CHEST, 2003, 124 (04) : 128S - 128S
  • [10] Efficacy and safety of fluticasone propionate/salmeterol 250/50 mcg Diskus administered once daily
    Kerwin, Edward M.
    Nathan, Robert A.
    Meltzer, Eli O.
    Ortega, Hector G.
    Yancey, Steven W.
    Schoaf, Lynne
    Dorinsky, Paul M.
    RESPIRATORY MEDICINE, 2008, 102 (04) : 495 - 504
12345